Synovial cellular and molecular markers in rheumatoid arthritis

Semin Immunopathol. 2017 Jun;39(4):385-393. doi: 10.1007/s00281-017-0631-3. Epub 2017 May 11.

Abstract

The profound alterations in the structure, cellular composition, and function of synovial tissue in rheumatoid arthritis (RA) are the basis for the persistent inflammation and cumulative joint destruction that are hallmarks of this disease. In RA, the synovium develops characteristics of a tertiary lymphoid organ, with extensive infiltration of lymphocytes and myeloid cells. Concurrently, the fibroblast-like synoviocytes undergo massive hyperplasia and acquire a tissue-invasive phenotype. In this review, we summarize key components of these processes, focusing on recently-described roles of selected molecular markers of these cellular components of RA synovitis.

Publication types

  • Review

MeSH terms

  • Animals
  • Antirheumatic Agents / pharmacology
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy
  • Arthritis, Rheumatoid / etiology*
  • Arthritis, Rheumatoid / metabolism*
  • Arthritis, Rheumatoid / pathology
  • Biomarkers*
  • Cell Communication / drug effects
  • Cell Communication / genetics
  • Cell Communication / immunology
  • Gene Expression Regulation / drug effects
  • Humans
  • Joint Capsule / drug effects
  • Joint Capsule / immunology*
  • Joint Capsule / metabolism*
  • Joint Capsule / pathology
  • Molecular Targeted Therapy
  • Signal Transduction / drug effects
  • Synovial Membrane / cytology
  • Synovial Membrane / immunology
  • Synovial Membrane / metabolism
  • Synovial Membrane / pathology

Substances

  • Antirheumatic Agents
  • Biomarkers